The VJ Sessions aim to bring together leading experts in the oncology community to support international collaboration and allow them to discuss what the latest advances in diagnosis & therapy actually mean in the clinic.
View our growing collection of on-demand roundtable discussions across a range of oncology specialties below or listen to the podcasts on the go.
![Lung Cancer](https://d1wb8a73cv4ze9.cloudfront.net/wp-content/uploads/2023/07/12102844/Lung-section-Header.jpg)
Lung Cancer
Drug treatment of operable NSCLC
CT screening in the UK
How to interpret ctDNA reports
EGFR Exon 20 insertions - identifying and managing patients in the UK
Highlights in Lung Cancer from WCLC 2022 with Lizza Hendriks & Tiziana VavalĂ
Highlights in Lung Cancer from ASCO 2022 with Jia Luo and Julia Rotow
BTOG 2022 UK panel discussion
Topics: The current state of UK lung cancer care, novel IO targets & therapeutic cancer vaccines and the deployment of genomic testing in the UK
EGFR-mutated NSCLC
Topics: Latest advances in EGFR-mutated NSCLC care including considerations around EGFR testing, first-line treatment options, immunotherapy, management of brain metastases, surveillance on therapy, reprofiling, the latest clinical trial data and what is on the horizon.
ESMO & WCLC 2021
Topics: Lung cancer screening in the UK, adjuvant radiotherapy, concomitant chemo-radiation, resected NSCLC data, molecular testing, POSEIDON & HER2-mutated NSCLC
ASCO 2021
BTOG 2021
IASLC WCLC 2020
ESMO 2020
![Breast Cancer](https://d1wb8a73cv4ze9.cloudfront.net/wp-content/uploads/2023/07/12102845/Breast-section-Header.jpg)
Breast Cancer
Highlights from SABCS 2023 with Sara Tolaney, Paolo Tarantino & Sarah Sammons
Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons
Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja
Topics: TROPiCS-02, MONARCH-3, DATA, SYNERGY and BELLINI.
Examining DESTINY-Breast04 with Matteo Lambertini & Evandro de Azambuja
Latest updates from ASCO 2022 with Paolo Tarantino & Romualdo Barroso
Updates in TNBC with Roberto Salgado & Marleen Kok
Topics: Treatment de-escalation, biomarkers and TILs
Highlights from SABCS 2021 with Hope Rugo & Dave Cescon
Topics: KEYNOTE-522, KEYNOTE-355; EMERALD, and more IO updates at SABCS
Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
Topics: KEYNOTE-522, KEYNOTE-355; NIMBUS, and more IO updates at SABCS
Immunotherapy updates at SABCS 2021
Topics: KEYNOTE-522, KEYNOTE-355; NIMBUS, and more IO updates at SABCS
ESMO 2021
ASCO 2021
Topics: OlympiA & olaparib, capecitabine, GeparNuevo & BEGONIA, CDK4/6, SERDs, BCL-2 & talazoparib
St. Gallen Consensus 2021
Topics: pCR & IO, carboplatin & olaparib, gene signature assays & CDK4/6 inhibitors
SABCS 2020
Topics: CDK4/6 inhibitors, RxPONDER & premenopausal pts, IO and more SABCS highlights
![GU Cancers](https://d1wb8a73cv4ze9.cloudfront.net/wp-content/uploads/2023/07/12102844/GU-section-Header.jpg)
GU Cancers
Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala
Topics: RADICALS-HD, FORMULA-509, and adaptive radiotherapy
Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff
Topics: TRITON3, TALAPRO-2, TROPHY-U-01, COSMIC-313, & CheckMate 9ER
ASCO GU Cancers Symposium 2022
Topics: PROpel, MAGNITUDE & ARASENS in prostate cancer and NEOAVAX, KN-564 and axitinib plus nivo in renal cell carcinoma
Prostate updates from ESMO 2021
Topics: Combined analysis from STAMPEDE, OS results from PEACE-1 & results from cohort 6 of COSMIC-021
Bladder updates at ESMO 2021
Bladder & Kidney at ASCO 2021
Bladder & Kidney at ASCO GU Cancers Symposium 2021
Prostate Cancer at ASCO GU Cancers Symposium 2021
![GI Cancers](https://d1wb8a73cv4ze9.cloudfront.net/wp-content/uploads/2023/07/12102843/GI-section-Header.jpg)
GI Cancers
Highlights from ESMO 2022 with Geoffrey Ku and Sam Klempner
ASCO GI Cancers Symposium 2022
Topics: TOPAZ-1 in biliary tract cancer, HIMALAYA & KRYSTAL-1, CIRCULATE-Japan & incorporating ctDNA in the clinic, ACCENT/IDEA & PD-1 blockade in MSI-high rectal cancer.
Upper GI updates from ESMO 2021
Topics: CheckMate 649, DESTINY-Gastric02, MAHOGANY & chemo in HER2+ gastric cancer, CLDN 18.2-targeted CAR-T, KRYSTAL-1 in CRC, PRODIGE 24 in PDAC & more